Identification of six novel SCN5A mutations in Japanese patients with Brugada syndrome

International Heart Journal

Volumn 52, Issue 1, 2011, Pages 27-31

  Nakajima, Tadashi ^a   Kaneko, Yoshiaki ^a   Saito, Akihiro ^a   Irie, Tadanobu ^a   Tange, Shoichi ^b   Iso, Tatsuya ^a   Kurabayashi, Masahiko ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MAEBASHI RED CROSS HOSPITAL   (Japan)

Author keywords

Brugada syndrome; Mutation; SCN5A

Indexed keywords

SODIUM CHANNEL NAV1.5;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BRUGADA SYNDROME; CARBOXY TERMINAL SEQUENCE; CARDIOPULMONARY ARREST; CLINICAL ARTICLE; CLINICAL FEATURE; ELECTROCARDIOGRAM; ETHNIC DIFFERENCE; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; JAPANESE; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RESUSCITATION; SCN5A GENE; SPLICING DEFECT; ST SEGMENT ELEVATION; SYNCOPE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BRUGADA SYNDROME; FEMALE; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; MUSCLE PROTEINS; MUTATION; MUTATION, MISSENSE; PHENOTYPE; PREVALENCE; SODIUM CHANNELS;

EID: 79951503310     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.52.27     Document Type: Article

References (32)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20: 1391-6.
2. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998; 392: 293-6.
3. London B, Michalec M, Mehdi H, et al. Mutation in glycerol-3- phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation 2007; 116: 2260-8.
4. Van Norstrand DW, Valdivia CR, Tester DJ, et al. Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation 2007; 116: 2253-9.
5. Antzelevitch C, Pollevick GD, Cordeiro JM, et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007; 115: 442-9.
6. Watanabe H, Koopmann TT, Le Scouarnec S, et al. Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest 2008; 118: 2260-8.
7. Delpón E, Cordeiro JM, Núñez L, et al. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol 2008; 1: 209-18.
8. Hu D, Barajas-Martinez H, Burashnikov E, et al. A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ Cardiovasc Genet 2009; 2: 270-8.
9. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002; 105: 1342-7.
10. Eckardt L, Probst V, Smits JP, et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 2005; 111: 257-63.
11. Morita H, Kusano KF, Miura D, et al. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome. Circulation 2008; 118: 1697-704.
12. Makita N, Behr E, Shimizu W, et al. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest 2008; 118: 2219-29.
13. Meregalli PG, Tan HL, Probst V, et al. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm 2009; 6: 341-8.
14. Kamakura S, Ohe T, Nakazawa K, et al. Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3. Circ Arrhythm Electrophysiol 2009; 2: 495-503.
15. Probst V, Veltmann C, Eckardt L, et al. Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FIN GER Brugada Syndrome Registry. Circulation 2010; 121: 635-43.
16. Wang Q, Li Z, Shen J, Keating MT. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics 1996; 34: 9-16.
17. Wei J, Wang DW, Alings M, et al. Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel. Circulation 1999; 99: 3165-71.
18. Makita N. Phenotypic overlap of cardiac sodium channelopathies: individual-specific or mutation-specific? Circ J 2009; 73: 810-7. (Review)
19. Napolitano C, Priori SG, Schwartz PJ, et al. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA 2005; 294: 2975-80.
20. Ackerman MJ, Splawski I, Makielski JC, et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 2004; 1: 600-7.
21. Esperer HD, Hoos O, Hottenrott K. Syncope due to Brugada syndrome in a young athlete. Br J Sports Med 2007; 41: 180-1.
22. García-Borbolla M, García-Borbolla R, Valenzuela LF, Trujillo F. Ventricular tachycardia induced by exercise testing in a patient with Brugada syndrome. Rev Esp Cardiol 2007; 60: 993-4. (Spanish)
23. Viswanathan PC, Benson DW, Balser JR. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J Clin Invest 2003; 111: 341-6.
24. Poelzing S, Forleo C, Samodell M, et al. SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene. Circulation 2006; 114: 368-76.
25. Lizotte E, Junttila MJ, Dube MP, et al. Genetic modulation of brugada syndrome by a common polymorphism. J Cardiovasc Electrophysiol 2009; 20: 1137-41.
26. Hwang HW, Chen JJ, Lin YJ, et al. R1193Q of SCN5A, a Brugada and long QT mutation, is a common polymorphism in Han Chinese. J Med Genet 2005; 42: e7.
27. Tan BH, Valdivia CR, Rok BA, et al. Common human SCN5A polymorphisms have altered electrophysiology when expressed in Q1077 splice variants. Heart Rhythm 2005; 2: 741-7.
28. Wang Q, Chen S, Chen Q, et al. The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel. J Med Genet 2004; 41: e66.
29. Huang H, Zhao J, Barrane FZ, Champagne J, Chahine M. Nav1.5/ R1193Q polymorphism is associated with both long QT and Brugada syndromes. Can J Cardiol 2006; 22: 309-13.
30. Baroudi G, Acharfi S, Larouche C, Chahine M. Expression and intracellular localization of an SCN5A double mutant R1232W/ T1620M implicated in Brugada syndrome. Circ Res 2002; 90: E11-6.
31. Makita N, Mochizuki N, Tsutsui H. Absence of a trafficking defect in R1232W/T1620M, a double SCN5A mutant responsible for Brugada syndrome. Circ J 2008; 72: 1018-9.
32. Kapplinger JD, Tester DJ, Alders M, et al. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 2010; 7: 33-46.